emisphere technologies inc (EMIS:OTC BB)

Executive Profile*

Background*

Mr. Alan L. Rubino has been the Chief Executive Officer and President of Emisphere Technologies, Inc., since September 13, 2012. Mr. Rubino serves as a Principal of Watchung Partners. Mr. Rubino served as Chief Executive Officer and President of New American Therapeutics Inc. He served as the President of Akrimax Pharmaceuticals LLC since February 2008 and also served as its Chief Executive Officer. He served as President and Chief Operating Officer of Pharmos Corporation ... from November 14, 2005 to December 12, 2007. He served as Executive Vice President and General Manager of Sales Teams Business of PDI, Inc. from January 29, 2004 to April 18, 2005. Mr. Rubino has 30 years of experience in pharmaceutical industry. He worked at Hoffmann-LaRoche for 24 years and held a variety of positions with broad responsibilities that encompassed Business Operations, Business Strategy, Human Resources and Sales and Marketing, including the launch of the first biotechnology product, Roferon-A(R). Mr. Rubino served as Senior Vice President of Business Operations of Hoffmann-LaRoche from 1997 to 2001 and served as its General Manager of Business Units. He served as Vice President for Business Operations and Corporate Officer of Hoffmann-LaRoche. He served as Senior Vice President of Pharmaceuticals Technology and Services Division of Cardinal Health. He joined Cardinal Health as part of the acquisition of BLPG, Inc., and served as its Executive Vice President & Managing Director. Mr. Rubino has been a Director of Aastrom Biosciences, Inc since September 30, 2005. He serves as a Director of Genisphere, Inc. He has been Director of Emisphere Technologies, Inc., since September 13, 2012. He serves as a Director of Rutgers Business School of Newark and New Brunswick. He is a member of the Rutgers Business School Advisory Board. He attended executive programs at both Harvard Business School and the University of Lausanne. Mr. Rubino received a B.A in Economics from Rutgers University in 1976 with a minor in Biology and Chemistry and has completed post-graduate and several Executive Management Courses from Harvard Business School and IMEDE in Europe.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
EMIS:US	$0.17 USD	-0.004

COMPETITOR COMPENSATION